Edition:
United States

MannKind Corp (MNKD.OQ)

MNKD.OQ on NASDAQ Stock Exchange Global Market

1.72USD
10 Dec 2018
Change (% chg)

-- (--)
Prev Close
$1.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
740,262
52-wk High
$4.05
52-wk Low
$0.98

Chart for

About

MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic... (more)

Overall

Beta: 3.00
Market Cap(Mil.): $526.55
Shares Outstanding(Mil.): 104.68
Dividend: --
Yield (%): --

Financials

  MNKD.OQ Industry Sector
P/E (TTM): 3.73 92.25 33.63
EPS (TTM): 1.35 -- --
ROI: -- 0.28 15.02
ROE: -- 0.94 16.60

Earnings vs. Estimates